We observed that our antibodies reduced the cell viability of cisplatin-resistant ovarian cancer cells considerably which was relying on OSMR signaling and therefore showed sensitization towards cisplatin therapy both in vitro and in vivo. The gene discussed is OSMR; the disease is ovarian carcinoma.